FDA Inspection 1004655 — AHS Investment Corp
The FDA completed an inspection of AHS Investment Corp on February 27, 2017 in South Hackensack, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- February 27, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- South Hackensack, NJ (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 1133 | 21 CFR 211.25(a) | GMP Training Frequency |
| 1728 | 21 CFR 211.87 | Retest of approved components/containers/closures |
| 2026 | 21 CFR 211.192 | Quality control unit review of records |